Hepatocellular proliferation in response to agonists of peroxisome proliferator-activated receptor alpha: a role for kupffer cells?

Background It has been proposed that PPARα agonists stimulate Kupffer cells in rodents which in turn, release mitogenic factors leading to hepatic hyperplasia, and eventually cancer. However, Kupffer cells do not express PPARα receptors, and PPARα agonists stimulate hepatocellular proliferation in both TNFα- and TNFα receptor-null mice, casting doubt on the involvement of Kupffer cells in the mitogenic response to PPARα agonists. This study was therefore designed to investigate whether the PPARα agonist PFOA and the Kupffer cell inhibitor methylpalmitate produce opposing effects on hepatocellular proliferation and Kupffer cell activity in vivo, in a manner that would implicate these cells in the mitogenic effects of PPARα agonists. Methods Male Sprague-Dawley rats were treated intravenously via the tail vein with methylpalmitate 24 hrs prior to perfluorooctanoic acid (PFOA), and were sacrificed 24 hrs later, one hr after an intraperitoneal injection of bromodeoxyuridine (BrdU). Sera were analyzed for TNFα and IL-1β. Liver sections were stained immunohistochemically and quantified for BrdU incorporated into DNA. Results Data show that PFOA remarkably stimulated hepatocellular proliferation in the absence of significant changes in the serum levels of either TNFα or IL-1β. In addition, methylpalmitate did not alter the levels of these mitogens in PFOA-treated animals, despite the fact that it significantly blocked the hepatocellular proliferative effect of PFOA. Correlation between hepatocellular proliferation and serum levels of TNFα or IL-1β was extremely poor. Conclusion It is unlikely that mechanisms involving Kupffer cells play an eminent role in the hepatic hyperplasia, and consequently hepatocarcinogenicity attributed to PPARα agonists. This conclusion is based on the above mentioned published data and the current findings showing animals treated with PFOA alone or in combination with methylpalmitate to have similar levels of serum TNFα and IL-1β, which are reliable indicators of Kupffer cell activity, despite a remarkable difference in hepatocellular proliferation.

[1]  I. Rusyn,et al.  Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators. , 2000, Cancer research.

[2]  J. Deluca,et al.  Tumor necrosis factor alpha is not required for WY14,643-induced cell proliferation. , 2001, Carcinogenesis.

[3]  I. Rusyn,et al.  WY-14 643 rapidly activates nuclear factor kappaB in Kupffer cells before hepatocytes. , 1998, Carcinogenesis.

[4]  M. Cunningham,et al.  Regulation of perfluorooctanoic acid–induced peroxisomal enzyme activities and hepatocellular growth by adrenal hormones , 1992, Hepatology.

[5]  H. Matthews,et al.  Rotenone, an anticarcinogen, inhibits cellular proliferation but not peroxisome proliferation in mouse liver. , 1995, Cancer letters.

[6]  H. K. Bojes,et al.  Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643. , 1997, Carcinogenesis.

[7]  J. Morrow,et al.  Evidence against peroxisome proliferation-induced hepatic oxidative damage. , 1997, Biochemical pharmacology.

[8]  M. Rolfe,et al.  Tumour necrosis factor α ( TNF α ) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes : a mediator of the hepatocarcinogenicity of peroxisome proliferators ? , 1997 .

[9]  B. Ghanayem,et al.  Induction of replicative DNA synthesis and PPAR alpha-dependent gene transcription by Wy-14 643 in primary rat hepatocyte and non-parenchymal cell co-cultures. , 1997, Carcinogenesis.

[10]  D. Germolec,et al.  Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators. , 1997, Carcinogenesis.

[11]  David J. Waxman,et al.  trans-activation of PPARα and PPARγ by structurally diverse environmental chemicals , 1999 .

[12]  R. Maronpot,et al.  Correlation of hepatocellular proliferation with hepatocarcinogenicity induced by the mutagenic noncarcinogen:carcinogen pair--2,6- and 2,4-diaminotoluene. , 1991, Toxicology and applied pharmacology.

[13]  J. Peters,et al.  Tumour necrosis factor alpha (TNFalpha): role in suppression of apoptosis by the peroxisome proliferator nafenopin. , 2000, Cellular and molecular biology.

[14]  Jihan Youssef,et al.  Activated Kupffer cells attenuate the liver response to the peroxisome proliferator perfluorooctanoic acid , 1997, Molecular and Cellular Biochemistry.

[15]  J. Reddy.  Carcinogenicity of peroxisome proliferators: evaluation and mechanisms. , 1990, Biochemical Society transactions.

[16]  C. Duve,et al.  A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[17]  David Y. Lai,et al.  PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance , 2003 .

[18]  M. Rolfe,et al.  Tumour necrosis factor alpha (TNF alpha) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators? , 1997, Carcinogenesis.

[19]  H. Nawata,et al.  Activation of retinoic X receptor and peroxisome proliferator–activated receptor‐γ inhibits nitric oxide and tumor necrosis factor‐α production in rat Kupffer cells , 2001 .

[20]  I. Rusyn,et al.  Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis. , 2000, Carcinogenesis.

[21]  J. Deluca,et al.  Tumor necrosis factor α is not required for WY14,643-induced cell proliferation , 2001 .

[22]  R. Cattley,et al.  Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. , 1988, Cancer research.

[23]  M. Monshouwer,et al.  Kupffer cell depletion partially prevents hepatic heme oxygenase 1 messenger RNA accumulation in systemic inflammation in mice: Role of interleukin 1β , 1998, Hepatology.

[24]  R. Schulte‐Hermann,et al.  Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously. , 1991, Cancer research.

[25]  J. Bucher,et al.  Early responses of the liver of B6C3F1 mice to the hepatocarcinogen oxazepam. , 1994, Toxicology and applied pharmacology.

[26]  I. Rusyn,et al.  Role of Kupffer cells in peroxisome proliferator-induced hepatocyte proliferation. , 1999, Drug metabolism reviews.